Trial Profile
A phase 1 first in human study to evaluate the safety, tolerability and pharmacokinetics of single ascending doses of intravenous AIC499
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 31 Jul 2018
Price :
$35
*
At a glance
- Drugs AIC-499 (Primary)
- Indications Gram-negative infections
- Focus Adverse reactions; First in man; Pharmacodynamics
- 31 Jul 2018 New trial record